Safety and efficacy of teneligliptin: A novel DPP-4 inhibitor for hemodialysis patients with type 2 diabetes

Hideo Otsuki, Takeo Kosaka, Kenzo Nakamura, Fumihiko Shimomura, Yoshitaka Kuwahara, Takuji Tsukamoto

Research output: Contribution to journalArticlepeer-review

34 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Safety and efficacy of teneligliptin: A novel DPP-4 inhibitor for hemodialysis patients with type 2 diabetes'. Together they form a unique fingerprint.

Medicine & Life Sciences